Léa Bernard

823 total citations
38 papers, 201 citations indexed

About

Léa Bernard is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Léa Bernard has authored 38 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 18 papers in Oncology and 12 papers in Genetics. Recurrent topics in Léa Bernard's work include Hematopoietic Stem Cell Transplantation (17 papers), Acute Myeloid Leukemia Research (9 papers) and Multiple Myeloma Research and Treatments (8 papers). Léa Bernard is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Acute Myeloid Leukemia Research (9 papers) and Multiple Myeloma Research and Treatments (8 papers). Léa Bernard collaborates with scholars based in Canada, United States and France. Léa Bernard's co-authors include Thomas Kiss, Imran Ahmad, Guy Sauvageau, Sandra Cohen, Jean Roy, Denis‐Claude Roy, Silvy Lachance, Nadia M. Bambace, Jean‐Sébastien Delisle and Lambert Busque and has published in prestigious journals such as Blood, British Journal of Haematology and Bone Marrow Transplantation.

In The Last Decade

Léa Bernard

33 papers receiving 197 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Léa Bernard Canada	8	117	113	54	37	37	38	201
Ilaria Scortechini Italy	10	174 1.5×	100 0.9×	56 1.0×	37 1.0×	20 0.5×	17	235
Christos Demosthenous Greece	8	77 0.7×	61 0.5×	71 1.3×	47 1.3×	20 0.5×	19	202
Immacolata Attolico Italy	6	82 0.7×	44 0.4×	27 0.5×	29 0.8×	28 0.8×	17	146
Anne‐Lise Ménard France	7	104 0.9×	57 0.5×	26 0.5×	36 1.0×	58 1.6×	15	187
Pilar Martínez‐Sánchez Spain	7	69 0.6×	58 0.5×	50 0.9×	14 0.4×	31 0.8×	18	129
Valério Maisano France	9	136 1.2×	90 0.8×	29 0.5×	72 1.9×	23 0.6×	18	208
N. Peter Germany	7	80 0.7×	60 0.5×	23 0.4×	16 0.4×	40 1.1×	8	167
Marion Loirat France	7	142 1.2×	81 0.7×	60 1.1×	42 1.1×	30 0.8×	8	189
Jiejing Qian China	10	162 1.4×	46 0.4×	74 1.4×	53 1.4×	33 0.9×	22	231
Jaszianne Tolbert United States	11	211 1.8×	186 1.6×	138 2.6×	47 1.3×	15 0.4×	29	324

Countries citing papers authored by Léa Bernard

Since Specialization

Citations

This map shows the geographic impact of Léa Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Léa Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Léa Bernard more than expected).

Fields of papers citing papers by Léa Bernard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Léa Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Léa Bernard. The network helps show where Léa Bernard may publish in the future.

Co-authorship network of co-authors of Léa Bernard

This figure shows the co-authorship network connecting the top 25 collaborators of Léa Bernard. A scholar is included among the top collaborators of Léa Bernard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Léa Bernard. Léa Bernard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mollica, Luigina, Imran Ahmad, Sandra Cohen, et al.. (2025). Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center Experience. Current Oncology. 32(3). 173–173. 1 indexed citations

Roy, Jean, Sandra Cohen, Guy Sauvageau, et al.. (2024). A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma Patients. Transplantation and Cellular Therapy. 31(1). 34.e1–34.e14.

DiPersio, John F., Guenther Koehne, Nirali N. Shah, et al.. (2024). A CD33-Deleted Allograft (Trem-cel) Enables Post-Hematopoietic Cell Transplant (HCT) Maintenance Dosing of Gemtuzumab Ozogamicin (GO) with Therapeutic Levels of Drug Exposure and Low Hematologic and Hepatic Toxicity in Patients with High-Risk Acute Myeloid Leukemia (AML). Blood. 144(Supplement 1). 2873–2873.

Koehne, Guenther, Benjamin Tomlinson, Hyung C. Suh, et al.. (2023). P1396: CD33-DELETED HEMATOPOIETIC STEM AND PROGENITOR CELLS DISPLAY NORMAL ENGRAFTMENT AFTER HEMATOPOIETIC CELL TRANSPLANT (HCT) AND TOLERATE POST-HCT GEMTUZUMAB OZOGAMICIN (GO) WITHOUT CYTOPENIAS. HemaSphere. 7(S3). e24418bc–e24418bc. 3 indexed citations

Bernard, Léa, et al.. (2023). Seminoma-associated orbitopathy mimicking thyroid-associated orbitopathy: report of a case and literature review. Orbit. 43(4). 480–485.

LeBlanc, Richard, Imran Ahmad, Jean‐Sébastien Delisle, et al.. (2022). Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD. Transplantation and Cellular Therapy. 29(1). 44.e1–44.e9. 2 indexed citations

Lachance, Silvy, Philippe Bouchard, Imran Ahmad, et al.. (2022). Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge. Transplantation and Cellular Therapy. 29(1). 34.e1–34.e7. 7 indexed citations

Ahmad, Imran, Jean‐Sébastien Delisle, Thomas Kiss, et al.. (2021). Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective. Transplantation and Cellular Therapy. 28(3). 145–151. 3 indexed citations

LeBlanc, Richard, Imran Ahmad, David Ogez, et al.. (2021). Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study. Bone Marrow Transplantation. 57(2). 252–260. 6 indexed citations

10.

Cohen, Sandra, Imran Ahmad, Jean‐Sébastien Delisle, et al.. (2020). Single UM171‐expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors. European Journal Of Haematology. 105(6). 808–811. 4 indexed citations

11.

LeBlanc, Richard, Imran Ahmad, Jean‐Sébastien Delisle, et al.. (2020). Newly diagnosed multiple myeloma patients treated with tandem auto‐allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only. Clinical Transplantation. 34(12). e14099–e14099. 6 indexed citations

12.

Ahmad, Imran, Nadia M. Bambace, Léa Bernard, et al.. (2019). Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease. Leukemia Research. 79. 75–80. 8 indexed citations

13.

Ahmad, Imran, Nadia M. Bambace, Léa Bernard, et al.. (2019). Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma. Biology of Blood and Marrow Transplantation. 26(1). 157–161. 14 indexed citations

14.

Roy, Denis‐Claude, Sandra Cohen, Jean‐Sébastien Delisle, et al.. (2019). Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence of GVHD prophylaxis. British Journal of Haematology. 186(5). 754–766. 14 indexed citations

15.

Cohen, Sandra, Jean Roy, Silvy Lachance, et al.. (2018). Single UM171 Expanded Cord Blood Permits Transplantation of Better HLA Matched Cords with Excellent Gvhd Relapse Free Survival. Blood. 132(Supplement 1). 4658–4658. 3 indexed citations

16.

Bouchard, Philippe, Sandra Cohen, Imran Ahmad, et al.. (2017). Impact of Carmustine (BCNU) Substitution for Bendamustine in the Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation for the Treatment of Lymphoma. Blood. 130. 2022–2022. 2 indexed citations

17.

Cohen, Sandra, Jean Roy, Silvy Lachance, et al.. (2017). Single UM171 Expanded Cord Blood Transplant Is Feasible, Safe, and Permits Transplantation of Better HLA Matched Cords with Very Low Transplant Related Mortality. Blood. 130(Suppl_1). 658–658. 3 indexed citations

18.

Cohen, Sandra, Jean Roy, Silvy Lachance, et al.. (2017). Single UM171 expanded cord blood transplant is feasible and safe, accelerates engraftment, reduces hospitalization length and most importantly improves HLA matching. Experimental Hematology. 53. S48–S49. 3 indexed citations

19.

Kim, Hyun Pyo, et al.. (2012). Flow cytometry‐based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia. Cytometry Part B Clinical Cytometry. 82B(5). 283–294. 10 indexed citations

20.

Holbro, Andreas, Imran Ahmad, Sandra Cohen, et al.. (2012). Safety and Cost-Effectiveness of Outpatient Autologous Stem Cell Transplantation in Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation. 19(4). 547–551. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact